ArticleFrontiers in oncology2024

Real-world use of first-line pembrolizumab + platinum + taxane combination regimens in recurrent / metastatic head and neck squamous cell carcinoma.

Christopher M Black et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.